Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Doxycycline hyclate

EU orphan designation number: EU/3/12/961   
Active ingredient: Doxycycline hyclate
Indication: Treatment of systemic amyloidosis caused by beta-2 microglobulin
Sponsor: Giampaolo Merlini
Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico, San Matteo and University of Pavia, Viale Camillo Golgi, 19, 27100 Pavia, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/03/2012 Orphan designation EMA/OD/120/11 (2012)1531 of 5/03/2012